Is Arbutus Biopharma Corp (NASDAQ: ABUS) Proving The Doubters Wrong?
Arbutus Biopharma Corp (ABUS) concluded trading on Wednesday at a closing price of $4.20, with 3.35 million shares of worth about $14.08 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 51.08% during that period and on October 16, 2024 the price saw a […]
Arbutus Biopharma Corp (ABUS) Outlook Starting To Look Brighter?
Arbutus Biopharma Corp (ABUS) concluded trading on Thursday at a closing price of $2.54, with 4.33 million shares of worth about $11.01 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 25.12% during that period and on Thursday the price saw a gain of […]
